HUT47553A - Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components - Google Patents

Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components

Info

Publication number
HUT47553A
HUT47553A HU884667A HU466788A HUT47553A HU T47553 A HUT47553 A HU T47553A HU 884667 A HU884667 A HU 884667A HU 466788 A HU466788 A HU 466788A HU T47553 A HUT47553 A HU T47553A
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
azitromycin
analogues
producing
compositions containing
Prior art date
Application number
HU884667A
Other languages
English (en)
Inventor
Jack S Remington
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUT47553A publication Critical patent/HUT47553A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU884667A 1987-09-10 1988-09-09 Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components HUT47553A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002317 WO1989002271A1 (en) 1987-09-10 1987-09-10 Azithromycin and derivatives as antiprotozoal agents

Publications (1)

Publication Number Publication Date
HUT47553A true HUT47553A (en) 1989-03-28

Family

ID=22202554

Family Applications (1)

Application Number Title Priority Date Filing Date
HU884667A HUT47553A (en) 1987-09-10 1988-09-09 Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components

Country Status (18)

Country Link
US (1) US4963531A (hu)
EP (1) EP0307128B1 (hu)
JP (1) JPH0667847B2 (hu)
KR (1) KR930011996B1 (hu)
AT (1) ATE74508T1 (hu)
AU (1) AU596029B2 (hu)
CA (1) CA1334574C (hu)
DE (1) DE3869880D1 (hu)
DK (1) DK175544B1 (hu)
HU (1) HUT47553A (hu)
IE (1) IE61507B1 (hu)
IL (1) IL87698A (hu)
MY (1) MY103388A (hu)
NZ (1) NZ226112A (hu)
PH (1) PH26229A (hu)
PT (1) PT88448B (hu)
WO (1) WO1989002271A1 (hu)
ZA (1) ZA886727B (hu)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
TW271400B (hu) * 1992-07-30 1996-03-01 Pfizer
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
CA2138643A1 (en) * 1993-05-05 1994-11-10 Jack S. Remington Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
CA2189001A1 (en) * 1994-04-26 1995-11-02 Nobuhiro Narita Medicinal composition as a remedy for nonsmall cell lung cancer
AU744318B2 (en) * 1994-04-29 2002-02-21 Pfizer Inc. Method of administering azithromycin
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
ES2163504T5 (es) * 1994-05-06 2008-05-16 Pfizer Inc. Formas de dosificacion de liberacion controlada de azitromicina.
US20030212123A1 (en) * 1997-05-05 2003-11-13 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
WO1999020639A2 (en) * 1997-10-16 1999-04-29 Pliva, Farmaceutska Industrija ,Dionicko, Drustvo NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
WO2001049697A1 (en) * 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
WO2002007736A1 (en) * 2000-07-24 2002-01-31 Cadila Pharmaceuticals Limited The process for manufacturing of clear liquid pharmaceutical composition of azithromycin
CA2417353C (en) 2000-07-25 2009-09-01 Laboratorio Silanes,S.A. De C.V. Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-one, and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
AU2001214115A1 (en) * 2000-08-01 2002-02-13 Habil F. Khorakiwala Process for the preparation of anhydrous azithromycin
AU2001280000A1 (en) 2000-08-23 2002-03-04 Jaweed Mukarram, Siddiqui Mohammed Process for preparation of anhydrous azithromycin
WO2002042315A2 (en) * 2000-11-27 2002-05-30 Biochemie S.A. Macrolide solvates
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
EP1671979B1 (en) 2001-05-22 2008-08-13 Pfizer Products Inc. New Cristal Form of Azithromycin
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
MXPA03010028A (es) 2001-05-22 2004-02-12 Pfizer Prod Inc Formas cristalinas de azitromicina.
OA12845A (en) * 2001-08-21 2006-09-15 Pfizer Prod Inc Single dose azithromycin for treating respiratory infections.
ES2324527T3 (es) * 2001-10-18 2009-08-10 Teva Pharmaceutical Industries Ltd. Composiciones de azitromicina estabilizadas.
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
MXPA04005105A (es) * 2001-12-21 2004-08-19 Pfizer Prod Inc Formulaciones de acitromicina directamente compresibles.
EP1455757A2 (en) * 2001-12-21 2004-09-15 Pfizer Products Inc. Methods for wet granulating azithromycin
JP2005526020A (ja) * 2002-02-01 2005-09-02 ファイザー・プロダクツ・インク アジスロマイシンの乾式造粒配合物
ES2220229B1 (es) * 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
BRPI0416534A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
BRPI0417348A (pt) 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
BRPI0417338A (pt) * 2003-12-04 2007-04-17 Pfizer Prod Inc formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
PT1691787E (pt) 2003-12-04 2008-09-02 Pfizer Prod Inc Método de formação de multipartículas farmacêuticas
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053653A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
CN1295719C (zh) * 2003-12-30 2007-01-17 郑玉庆 远程智能型变压器
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
CN100427499C (zh) * 2005-12-20 2008-10-22 山东诚创医药技术开发有限公司 一种阿奇霉素的可溶性盐及其制备方法
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
AU8280087A (en) * 1987-09-10 1989-04-17 Pfizer Inc. Azithromycin and derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
ZA886727B (en) 1990-04-25
IE882762L (en) 1989-03-10
AU596029B2 (en) 1990-04-12
DK502888A (da) 1989-03-13
KR930011996B1 (ko) 1993-12-23
PT88448B (pt) 1992-10-30
CA1334574C (en) 1995-02-28
DK502888D0 (da) 1988-09-09
PH26229A (en) 1992-04-01
EP0307128B1 (en) 1992-04-08
IL87698A0 (en) 1989-02-28
IE61507B1 (en) 1994-11-02
AU2206188A (en) 1989-05-11
IL87698A (en) 1992-12-01
WO1989002271A1 (en) 1989-03-23
DE3869880D1 (de) 1992-05-14
PT88448A (pt) 1989-07-31
DK175544B1 (da) 2004-11-29
EP0307128A2 (en) 1989-03-15
NZ226112A (en) 1997-03-24
MY103388A (en) 1993-06-30
JPH0283326A (ja) 1990-03-23
ATE74508T1 (de) 1992-04-15
US4963531A (en) 1990-10-16
JPH0667847B2 (ja) 1994-08-31
EP0307128A3 (en) 1990-07-04
KR890004709A (ko) 1989-05-09

Similar Documents

Publication Publication Date Title
HUT47553A (en) Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components
HUT41809A (en) Process for preparing dideoxy-nucleosides and pharmaceutical compositions containing such compounds
JPS6470457A (en) Local remedy for skin damaged by beam
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
HUT51606A (en) Process for producing n-benzthiazolyl-carboxamide derivatives
HUT48266A (en) Process for producing 2,3'-dideoxy-2'-fluoronukleozides and pharmaceutical compositions containing them as active componenets
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
HUT41951A (en) Process for producing insecticide compositions containing fluorinated ethers as active agents and process for producing the active agents
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
EP0158212A3 (en) Citric-acid esters as blowing agents for working up plastics
HUT43828A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
HUT48268A (en) Process for producing pharmaceutical nukleozide and pharmaceutical compositions containing them
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
HUT46688A (en) Fungicide compositions containing carbamoyl-imidazol derivatives as active components and process for producing the active components
HUT46930A (en) Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT45000A (en) Fungicide compositions containing terciery amines as active components and process for producing the active components
HU9303227D0 (en) D-3 vitamine analogues and process for producing them
HUT47096A (en) Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components
IL90499A0 (en) Therapeutic uses of 2',5'-oligoadenylates
HUT52958A (en) Process for production of medical compositions assuring the constant release of the active substance
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
DK218388A (da) Aktivt princip isoleret fra hajvaev
HUT46838A (en) Pesticide compositions containing 2,5-bis-pyridyl-1,3,4-thiadiazol derivatives as active components and process for producing the active components
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments